Skip to main content

. 1966 Mar 26;1(5490):770–774. doi: 10.1136/bmj.1.5490.770

Review of Regional Limb Perfusion with Melphalan for Malignant Melanoma^*

W T Irvine, R J Luck

PMCID: PMC1844535 PMID: 5910107

770

Images in this article

Fig. 1
on p.773

Fig. 2
on p.773

Fig. 3
on p.773

Fig. 4
on p.773

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

CHARALAMBIDIS P. H., PATTERSON W. B. A clinical study of 250 patients with malignant melanoma. Surg Gynecol Obstet. 1962 Sep;115:333–341. [PubMed] [Google Scholar]
COBB J. P., WALKER D. G. STUDIES ON HUMAN MELANOMA CELLS IN TISSUE CULTURE. II. EFFECTS OF SEVERAL CANCER CHEMOTHERAPEUTIC AGENTS ON CYTOLOGY AND GROWTH. Acta Unio Int Contra Cancrum. 1964;20:206–208. [PubMed] [Google Scholar]
CREECH O., Jr, KREMENTZ E. T., RYAN R. F., WINBLAD J. N. Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit. Ann Surg. 1958 Oct;148(4):616–632. doi: 10.1097/00000658-195810000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
FORTNER J. G., BOOHER R. J., PACK G. T. RESULTS OF GROIN DISSECTION FOR MALIGNANT MELANOMA IN 220 PATIENTS. Surgery. 1964 Apr;55:485–494. [PubMed] [Google Scholar]
HOBBS J. T., EDWARDS E. A. Measurement of blood-flow in the femoral artery. A simplified apparatus using the indicator-dilution principle. Lancet. 1962 Aug 11;2(7250):273–274. doi: 10.1016/s0140-6736(62)90175-7. [DOI] [PubMed] [Google Scholar]
KLOPP C. T., ALFORD T. C., BATEMAN J., BERRY G. N., WINSHIP T. Fractionated intra-arterial cancer; chemotherapy with methyl bis amine hydrochloride; a preliminary report. Ann Surg. 1950 Oct;132(4):811–832. doi: 10.1097/00000658-195010000-00018. [DOI] [PMC free article] [PubMed] [Google Scholar]
KONDO T. THE ADVERSE EFFECTS OF CANCER CHEMOTHERAPY. Acta Unio Int Contra Cancrum. 1964;20:194–198. [PubMed] [Google Scholar]
LEBRUN J., SMETS W. PERFUSION REGIONALE PAR CIRCULATION EXTRA-CORPORELLE. PREMIERS RESULTATS. Acta Unio Int Contra Cancrum. 1964;20:459–461. [PubMed] [Google Scholar]
MCNEER G. MALIGNANT MELANOMA. Surg Gynecol Obstet. 1965 Feb;120:343–344. [PubMed] [Google Scholar]
MEYER H. W., GUMPORT S. L. Malignant melanoma; appraisal of the disease and analysis of 105 cases. Ann Surg. 1953 Oct;138(4):643–660. doi: 10.1097/00000658-195310000-00017. [DOI] [PMC free article] [PubMed] [Google Scholar]
PACK G. T., GERBER D. M., SCHARNAGEL I. M. End results in the treatment of malignant melanoma; a report of 1190 cases. Ann Surg. 1952 Dec;136(6):905–911. doi: 10.1097/00000658-195212000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
SMITH J. L., Jr, STEHLIN J. S., Jr, CLARK R. L. HISTOPATHOLOGICAL CHANGES IN MALIGNANT MELANOMA AND NORMAL TISSUES FOLLOWING REGIONAL PERFUSION WITH L-PHENYLALANINE MUSTARD (L-SARCOLYSIN). Acta Unio Int Contra Cancrum. 1964;20:451–454. [PubMed] [Google Scholar]
SOUTHWICK H. W., SLAUGHTER D. P., HINKAMP J. F., JOHNSON F. E. The role of regional node dissection in the treatment of malignant melanoma. Arch Surg. 1962 Jul;85:63–69. doi: 10.1001/archsurg.1962.01310010067009. [DOI] [PubMed] [Google Scholar]
TREIDMAN L., McNEER G. Prognosis with local metastasis and recurrence in malignant melanoma. Ann N Y Acad Sci. 1963 Feb 15;100:123–130. doi: 10.1111/j.1749-6632.1963.tb57117.x. [DOI] [PubMed] [Google Scholar]
VOGLER W. R., PERDUE G. D., WILKINS S. A., Jr A clinical evaluation of malignant melanoma. Surg Gynecol Obstet. 1958 May;106(5):586–594. [PubMed] [Google Scholar]

ACTIONS

RESOURCES